Results 191 to 200 of about 1,253,570 (258)

Lobeglitazone and the risk of renal progression in Korean patients with type 2 diabetes mellitus: a retrospective cohort study. [PDF]

BMJ Open
Hong SH, Lee H, Lee SY, Sung YA, Hong YS, Song DK, Jung H, Kim MH.   +7 more
europepmc   +1 more source

A rare case of gliclazide-induced symptomatic bradycardia in type 2 diabetes mellitus. [PDF]

JCEM Case Rep
Kumar A, Garg S, Bharti P, Zutshi B, Ambedare S, Yadav V.   +5 more
europepmc   +1 more source

Antidiabetic drug and chronic respiratory disease in type 2 diabetes: a network meta-analysis and Mendelian randomization analysis. [PDF]

Ther Adv Endocrinol Metab
Patel I, Chai YH, Wang ZQ, Xu H, Zhang JY, Simo R, Tang XY, Zhou JB.   +7 more
europepmc   +1 more source

The beta-cell sulfonylurea receptor.

Advances in experimental medicine and biology, 1993
Ashcroft, S, Niki, I, Kenna, S, Weng, L, Skeer, J, Coles, B, Ashcroft, F   +6 more
openaire   +2 more sources

Use of Glucagon-Like Peptide-1 Receptor Agonists and Risk of Parkinson's Disease: Scandinavian Cohort Study. [PDF]

Diabetes Obes Metab
Engström A, Svanström H, Hviid A, Eliasson B, Gudbjörnsdottir S, Wintzell V, Hveem K, Jonasson C, Melbye M, Ueda P, Pasternak B.   +10 more
europepmc   +1 more source

Comparative effectiveness of sulfonylureas on kidney outcomes in adults with type 2 diabetes and moderate cardiovascular risk: a target trial emulation. [PDF]

BMJ Open Diabetes Res Care
Sklepinski S, Ratzki-Leewing AA, Herrin J, Swarna KS, Deng Y, Polley EC, Neumiller JJ, Galindo RJ, Umpierrez GE, Ross JS, Brito JP, Montori VM, Mickelson MM, McCoy RG.   +13 more
europepmc   +1 more source

Glucagon-like peptide 1 receptor agonist discontinuation and risks of major adverse cardiovascular events in adults with type 2 diabetes: target trial emulation. [PDF]

BMJ Med
Xie Y, Choi T, Al-Aly Z.
europepmc   +1 more source

Kidney outcomes with GLP-1 receptor agonists in people with type 2 diabetes already receiving SGLT2 inhibitors: a target trial emulation study using UK primary care data.

Lancet Prim Care
Jansz TT, McGovern AP, Young KG, Dinsdale MM, Cardoso P, Shields BM, Hattersley AT, Jones AG, Pearson ER, Bingham C, Oram RA, Dennis JM.   +11 more
europepmc   +1 more source

Publisher's note. [PDF]

Function (Oxf)
europepmc   +1 more source

Causal association between antidiabetic drug targets and risk of Bell's palsy: A 2-sample Mendelian randomization study. [PDF]

Medicine (Baltimore)
Lu K, Ye L, Yi X, He Y.
europepmc   +1 more source